Rising PSA
Showing 1 - 25 of 1,911
Prostate Cancer Trial in Aurora, Fort Collins (Grape Seed Extract)
Recruiting
- Prostate Cancer
- Grape Seed Extract
-
Aurora, Colorado
- +1 more
Aug 22, 2022
Prostate Cancer Trial in Lexington (ArtemiCoffee)
Not yet recruiting
- Prostate Cancer
-
Lexington, KentuckyUniversity of Kentucky
Jul 25, 2022
Prostate Cancer Trial in United States (Abiraterone Acetate, Prednisone 5Mg Tab, DST-2970 (Abiraterone))
Active, not recruiting
- Prostate Cancer
- Abiraterone Acetate
- +2 more
-
Miami, Florida
- +4 more
Dec 14, 2022
Prostatic Tumors Trial in Worldwide (Antiandrogen, Antiandrogen+docetaxel)
Active, not recruiting
- Prostatic Neoplasms
-
Copenhagen, Denmark
- +4 more
Aug 12, 2021
Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)
Completed
- Prostate Cancer
- Abiraterone acetate
- +2 more
-
Chicago, Illinois
- +15 more
Oct 25, 2021
Prostatic Tumors, Prostate Cancer, Recurrence Trial in France, Spain, Switzerland ([18F]CTT1057, [68Ga]Ga-PSMA-11)
Recruiting
- Prostatic Neoplasms
- +2 more
-
Marseille Cedex 05, France
- +8 more
Aug 9, 2022
Prostate Cancer Recurrent, Prostate Cancer, Prostate Adenocarcinoma Trial in Lexington (Epidiolex Oral Liquid Product)
Completed
- Prostate Cancer Recurrent
- +2 more
- Epidiolex Oral Liquid Product
-
Lexington, KentuckyMarkey Cancer Center
Oct 7, 2021
Prostate Cancer Trial in Toronto (Metformin, Atorvastatin, Placebo (corresponding to metformin))
Withdrawn
- Prostate Cancer
- Metformin
- +3 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Apr 16, 2021
Prostate Cancer Trial in Canada, Lithuania, United States (No intervention)
Completed
- Prostate Cancer
- No intervention
-
Baltimore, Maryland
- +7 more
Mar 7, 2022
Castration-resistant Prostate Cancer Trial in Vancouver, Toronto (Abiraterone + prednisone, Enzalutamide)
Completed
- Castration-resistant Prostate Cancer
- Abiraterone + prednisone
- Enzalutamide
-
Vancouver, British Columbia, Canada
- +1 more
Jan 10, 2020
Adenocarcinoma of the Prostate Trial in United States (Muscadine Plus, Placebos)
Terminated
- Adenocarcinoma of the Prostate
- Muscadine Plus
- Placebos
-
Duarte, California
- +12 more
Dec 6, 2022
Prostate Cancer, Prostate Cancer Recurrent Trial in Mineola (Metformin Hydrochloride Extended Release 750mg)
Completed
- Prostate Cancer
- Prostate Cancer Recurrent
- Metformin Hydrochloride Extended Release 750mg
-
Mineola, New YorkWinthrop University Hospital
Feb 2, 2022
Metastatic Castration Resistant Prostate Cancer, Metastatic Cancer, Solid Tumor Trial in United States (Nivolumab, Ipilimumab)
Active, not recruiting
- Metastatic Castration Resistant Prostate Cancer
- +2 more
-
San Diego, California
- +7 more
Jan 23, 2023
Prostate Cancer, Prostatic Tumor Trial in United States (abiraterone acetate in combination with prednisone)
Active, not recruiting
- Prostate Cancer
- Prostatic Neoplasm
- abiraterone acetate in combination with prednisone
-
Homewood, Alabama
- +44 more
Jan 17, 2023
Prostate Cancer Trial in Sydney (Copper-64 labelled SAR-Bombesin)
Recruiting
- Prostate Cancer
- Copper-64 labelled SAR-Bombesin
-
Sydney, New South Wales, AustraliaSt Vincent's Hospital
Jan 8, 2023
Prostate Cancer Trial in Australia, New Zealand (Adjuvant Radiotherapy, Early Salvage Radiotherapy)
Active, not recruiting
- Prostate Cancer
- Adjuvant Radiotherapy
- Early Salvage Radiotherapy
-
Campbelltown, New South Wales, Australia
- +35 more
Nov 16, 2022
Post Prostatectomy Trial in Toronto ([18F]DCFPyL PET/MRI scan, Stereotactic Ablative Radiotherapy)
Recruiting
- Post Prostatectomy
- [18F]DCFPyL PET/MRI scan
- Stereotactic Ablative Radiotherapy
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Dec 31, 2021
Prostate Cancer, Prostate Cancer Recurrent, Prostate Cancer Metastatic Trial in Belgium (Darolutamide, metastasis-directed
Recruiting
- Prostate Cancer
- +4 more
- Darolutamide
- metastasis-directed treatment
-
Aalst, Belgium
- +6 more
Jan 25, 2023
Prostate Cancer, Recurrent Prostate Cancer, PET Positive Trial run by the National Cancer Institute (NCI) (Enzalutamide, M9241)
Not yet recruiting
- Prostate Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 27, 2023
Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell
Terminated
- Prostatic Neoplasms
- Prostate Cancer
- Autologus elutriated monocyte placebo vaccine
- Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022